OphthaTherapy 2020-05-26T09:13:34+02:00 Marcin Kuzma Open Journal Systems <p>"OphthaTherapy" (abbr.: OphthaTherapy) is a peer-reviewed scientific quarterly publishing papers in: ophthalmology, ophthalmic surgery (including minimally invasive surgery and laser therapy), pharmacological treatment of eye diseases, including glaucoma, as well as work in the contactology. The journal is on the list of the Polish Ministry of Science and Higher Education. For publishing the article, the author receives 20 points.<br>We encourage you to submit: original papers, review articles, case reports, rapid communication, research letters, hypotheses, meeting proceedings, letter to the editor. We guarantee fast publication. There are no submission or processing charges.</p> Coronavirus and the eyes. The possibilities of infection transmission, clinical symptoms and prophylaxis in the ophthalmic office 2020-04-28T09:02:02+02:00 Marek E. Prost <p>Apart from conjunctivitis, SAR S-CoV-2 virus does not affect the eyes. However, it remains one of the main routes for the virus to enter the human body, so special methods of eye protection both for patients and medical personnel are necessary. The paper presents recommendations for eye protection in ophthalmic practices with special attention to the problem of preparing the equipment for examination and sterilization of diagnostic equipment.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Adaptive optics: a new technology in diagnostic imaging 2020-04-28T09:01:44+02:00 Jaromir Wasyluk Ilona Kaczmarek Małgorzata Myślińska Marta Dubisz <p>The adaptive optics (AO) technology has become a valuable diagnostic tool in vision research for studying retinal microscopic structure and function. It is an infrared adaptive optics retinal camera that allows non-invasive visualization of cone photoreceptor cells, the retinal vessel wall and lumen diameter, nerve fibers, and structure of lamina cribrosa, that remain invisible with other current diagnostic techniques. The AO technology may provide information about the pathologic changes in the retina, even in the absence of structural or functional abnormalities in the current diagnostic imaging. The rtx1<sup>TM</sup> (Imagine Eyes, France) is the only AO imaging device that has received regulatory clearance for ophthalmic examinations in multiple countries. In this article we present a brief overview of AO development, and its evolving range of applications in ophthalmic diagnostics.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Pigment epithelial detachment: multimodal diagnosis in clinical practice. Part two 2020-04-28T09:01:41+02:00 Jan Kucharczuk Katarzyna Lahutta-Kordys <p>Pigment epithelial detachment is a common pathology occurring in various retinal diseases. This diagnosis is used very often, but not always in the correct sense and without a clear distinction between its types. Different pathogenesis and type of lesions are associated with characteristic features in fluorescein angiography, autofluorescence, spectral optical coherent tomography and angiographic examination based on optical coherent tomography. In this article we will try to draw attention to the essential elements used in daily practice multimodal diagnosis of this pathology which allows us correctly determine its type, natural course and therapeutic management.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Cell therapy in degenerative retinal diseases: expectations and threats 2020-04-28T09:01:38+02:00 Anna Machalińska <p>Currently, for many retinal degenerative diseases there is no effective treatment based on disease etiology. Neurotrophic factors secreted by the applied cells are responsible for improved morphology and function of degenerative retina. Moreover, these cells present immunomodulatory effect and reduce the inflammatory response of the damaged tissue. The best effect is obtained at the initial stage of the disease. Despite promising preliminary results, cell therapy requires further investigation to evaluate its efficacy and long-term safety. It is worth to underline that cell therapy should be conducted only as part of free clinical trials in certified research centers after obtaining the patient's informed consent for treatment.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. The potential usage of D2 dopaminergic agonists in the treatment of VEGF-related eye diseases 2020-04-28T09:01:35+02:00 Maciej Osęka Katarzyna Saładziak Agnieszka Jamrozy-Witkowska Jacek Dziedziak Agnieszka Cudnoch-Jędrzejewska Anna Święch <p>Dopamine and D<sub>2</sub> dopaminergic agonists inhibit endothelial growth factor (VEGF). This effect has been proven in many types of cancer and in ovarian hyperstimulation syndrome. Experimental studies indicate the potential use of these substances in the treatment of eye diseases with increased VEGF release, such as exudative AMD, diabetic macular edema and proliferative diabetic retinopathy. This paper presents a review of the latest literature on the potential use of D<sub>2</sub> dopaminergic agonists in the treatment of vascular endothelial growth factor (VEGF) related diseases.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Zoonoses in ophthalmology. Part 2. Ocular larva migrans syndrome 2020-04-28T09:01:32+02:00 Piotr Borkowski <p>Ocular toxocariasis, or ocular larva migrans syndrome, is a parasitic disease of the eye caused by non-human species of roundworms, usually canine (<em>Toxocara canis</em>), which accidentally migrated into the eyeball. Although this disease is rare, in Poland it is the second infectious cause of posterior uveitis (11.8%). Additional and commercially available research in Poland that can be useful in this disease is of limited value, so the diagnosis should be clinical. This article gathers data from the literature on epidemiology, clinical course, diagnosis and actual principles of ocular toxocariasis treatment described from the point of view of an experienced infectious and parasitic diseases specialist.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Capsular bag distension syndrome: an uncommon complication following cataract surgery 2020-04-28T09:01:30+02:00 Piotr Kanclerz Katarzyna Przewłócka <p>Capsular bag distension syndrome is an uncommon complication following cataract extraction, which may occur even several years after surgery. The main symptoms include a gradual or sudden development of myopia and – in cases with opaque intracapsular fluid – a decrease in visual acuity. Anterior segment-optical coherence tomography is useful in confirming the diagnosis, however, Scheimpflug imaging or ultrasound biomicroscopy can also be considered. Nd:YAG posterior (or anterior) capsulotomy is an established treatment method. An advantage of surgical treatment is the feasibility of removing the intracapsular fluid completely. This article presents the modern classification, diagnostic methods and principles of management in the capsular bag distension syndrome.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Outcomes of posterior chamber iris-claw intraocular lenses implantation in aphakic eyes with insufficient capsular support: retrospective observational study 2020-04-28T09:01:28+02:00 Ilona Kaczmarek Jaromir Wasyluk Ilona Jędrzejewska Małgorzata Myślińska Marek E. Prost <p><strong>Background</strong>: Implantation of posterior chamber iris-claw intraocular lenses (IOLs) is often used in the surgical management of aphakia with inadequate capsular support. The purpose of the study was to evaluate the anatomical and functional outcomes and complication rate after implantation of a posterior chamber irisclaw aphakic IOL in eyes with insufficient capsular support.<br><strong>Methods</strong>: This retrospective observational study comprised patients without adequate capsular support undergoing posterior iris-claw aphakic IOL implantation between 2016 and 2018.<br><strong>Results</strong>: The study comprised 44 eyes of 44 patients. The mean follow-up was 12 months (range from 1 to 24 months). The IOLs were inserted during primary lens surgery in five eyes (11.36%), during a posterior chamber IOL exchange procedure in 24 eyes (54.55%), and as a secondary procedure in 15 aphakic eyes (34.09%). The final mean best corrected visual acuity (BCVA) was significantly better than preoperatively (0.49 ± 0.33 vs 0.36 ± 0.26, Snellen decimals) (P &lt; 0.05). The most common complication after surgery was transient elevated intraocular pressure (10 eyes; 22.73%).<br><strong>Conclusions</strong>: The posterior chamber iris-claw aphakic IOLs provided good anatomical and functional outcomes and can be used for a wide range of indications in eyes without adequate capsular support.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Iris plastic surgery. Part 2. Surgery with iris implants and combined techniques. A case series report 2020-04-28T09:01:25+02:00 Adam Cywiński <p>The article describes possibilities and indications for surgical correction of iris defects using artificial implants and their combinations with suture techniques in five cases from the author's own material. All patients gave informed consent for medical procedures. Using partial or total implants of the iris, including artificial iris, we can correct almost all iris losses and imperfections. Iris implants should be considered if simple suture of the iris is insufficient in obtaining the intended effect. This article presents five cases of surgical iris reconstrucion both in congential and acquired iridial defects.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. Biomolecular quantum resonance in the treatment of dry eye disease 2020-04-28T09:00:57+02:00 Piotr Fryczkowski <p>Balancing the composition of tears and, consequently, restoring the homeostasis of ocular surface, is difficult to achieve. This is due to the complex composition of tears, the variety of secretory glands involved, as well as complex and not fully understood interactions affecting the composition, quality, and quantity of tears. The application of Biomolecular Quantum Resonance technology Rexon Eye<sup>TM</sup> (Resono Ophthalmic, Italy) is based on providing quantum (portions) of high-frequency electromagnetic energy (4–64 MHz) at low power whose interaction with the transport of ions, proteins of cell membranes, and cells changes cell performance. The use of new technology in the treatment of dry eye syndrome combines existing applications of Biomolecular Quantum Resonance such as surgery, treatment of wounds, treatment of bone fractures, as well as treatment pain.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o. "Current Concepts in Ophthalmology": A new manual on the publishing market 2020-05-26T09:13:34+02:00 Robert Rejdak <p>Book review: Grzybowski A (ed). Current Concepts in Ophthalmology. Springer International Publishing, 2020: 302. ISBN 978-3-030-25388-2.</p> 2020-03-31T00:00:00+02:00 Copyright (c) 2020 Medical Education sp. z o.o.